ORIC Pharmaceuticals Inc logo

ORIC Pharmaceuticals Inc

NAS:ORIC (USA)  
$ 10.12 -0.2 (-1.94%) 10:08 PM EST
At Loss
P/B:
2.28
Market Cap:
$ 691.98M
Enterprise V:
$ 477.13M
Volume:
572.56K
Avg Vol (2M):
417.76K
Also Trade In:
Volume:
572.56K
At Loss
Avg Vol (2M):
417.76K

Business Description

Description
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.
Name Current Vs Industry Vs History
Cash-To-Debt 83.32
Equity-to-Asset 0.9
Debt-to-Equity 0.01
Debt-to-EBITDA -0.03
Interest Coverage No Debt
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -14.6
3-Year EPS without NRI Growth Rate -14.8
3-Year FCF Growth Rate -15.3
Name Current Vs Industry Vs History
5-Day RSI 21.9
9-Day RSI 35.87
14-Day RSI 43.68
6-1 Month Momentum % 17.83
12-1 Month Momentum % 130.99

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 12.26
Quick Ratio 12.26
Cash Ratio 12

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -17.9
Shareholder Yield % -0.06
Name Current Vs Industry Vs History
ROE % -40.31
ROA % -36.47
ROIC % -243.71
ROC (Joel Greenblatt) % -3226.22
ROCE % -42.25

Financials (Next Earnings Date:2024-03-15 Est.)

ORIC's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ORIC

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

ORIC Pharmaceuticals Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -1.99
Beta 0.53
Volatility % 79.42
14-Day RSI 43.68
14-Day ATR ($) 0.742213
20-Day SMA ($) 11.3255
12-1 Month Momentum % 130.99
52-Week Range ($) 4.09 - 13.42
Shares Outstanding (Mil) 67.05

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

ORIC Pharmaceuticals Inc Filings

Filing Date Document Date Form
No Filing Data

ORIC Pharmaceuticals Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

ORIC Pharmaceuticals Inc Frequently Asked Questions

What is ORIC Pharmaceuticals Inc(ORIC)'s stock price today?
The current price of ORIC is $10.12. The 52 week high of ORIC is $13.42 and 52 week low is $4.09.
When is next earnings date of ORIC Pharmaceuticals Inc(ORIC)?
The next earnings date of ORIC Pharmaceuticals Inc(ORIC) is 2024-03-15 Est..
Does ORIC Pharmaceuticals Inc(ORIC) pay dividends? If so, how much?
ORIC Pharmaceuticals Inc(ORIC) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1